PIM
ADPT icon

Platinum Investment Management’s Adaptive Biotechnologies ADPT Stock Holding History

Platinum Investment Management’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-366,230
Closed -$2.46M – 145
2023
Q2 		$2.46M Hold
366,230
– – 0.09% 75
2023
Q1 		$3.23M Hold
366,230
– – 0.11% 68
2022
Q4 		$2.8M Buy
366,230
+102,739
+39% +$799K 0.11% 69
2022
Q3 		$1.88M Sell
263,491
-31,168
-11% -$294K 0.08% 79
2022
Q2 		$2.38M Buy
294,659
+149,494
+103% +$1.31M 0.09% 75
2022
Q1 		$2.02M Buy
145,165
+30,747
+27% +$483K 0.06% 82
2021
Q4 		$3.21M Buy
114,418
+32,524
+40% +$997K 0.09% 77
2021
Q3 		$2.78M Buy
81,894
+23,004
+39% +$832K 0.08% 87
2021
Q2 		$2.41M Buy
58,890
+13,058
+28% +$508K 0.06% 88
2021
Q1 		$1.84M Buy
45,832
+15,804
+53% +$855K 0.04% 91
2020
Q4 		$1.78M Hold
30,028
– – 0.04% 96
2020
Q3 		$1.46M Sell
30,028
-18,862
-39% -$793K 0.04% 93
2020
Q2 		$2.37M Buy
48,890
+4,108
+9% +$150K 0.05% 76
2020
Q1 		$1.24M Buy
+44,782
New +$1.25M 0.03% 92

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AAP
Aristotle Atlantic Partners Sarasota, Florida $2.14B AUM 37.01% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Platinum Investment Management's ADPT Position: Q3 2023 in Review

Platinum Investment Management sold out of Adaptive Biotechnologies (ADPT) in Q3 2023, closing a stake of 366,230 shares — an estimated $2.46M sold.

Platinum Investment Management first reported a position in ADPT in Q1 2020 and held it in 14 quarters. The position peaked at $3.23M in Q1 2023. 190 funds tracked by Wall St. Rank hold ADPT as of Q3 2023.

  • Platinum Investment Management reported no remaining Adaptive Biotechnologies position as of Q3 2023 after selling out during the quarter.
  • Platinum Investment Management sold 366,230 Adaptive Biotechnologies shares in Q3 2023, an estimated $2.46M.
  • Platinum Investment Management first reported a position in Adaptive Biotechnologies in Q1 2020 and held it in 14 quarters.
  • Platinum Investment Management's Adaptive Biotechnologies position peaked at $3.23M in Q1 2023.
  • 190 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2023.

Based on Platinum Investment Management's 13F filing for Q3 2023, filed 3 Nov 2023.